Kolmar teams up with Sungkyunkwan Univ to develop recombinant human collagen

Lee Sae-bom and Minu Kim 2022. 1. 10. 15:27
글자크기 설정 파란원을 좌우로 움직이시면 글자크기가 변경 됩니다.

이 글자크기로 변경됩니다.

(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.

[Source: Kolmar Korea]
Kolmar Korea, a cosmetics and health care company based in Seoul, has joined hands with Sungkyunkwan University¡¯s Biofoundry Center to develop recombinant human collagen that could be applied to functional cosmetics, food and therapeutics.

A biofoundry is an integrated molecular biology platform that includes robotic liquid-handling and high-throughput analytical equipment for a synthetic biology process called 'cell factory'. Synthetic biology is a science that artificially manipulates the metabolic circuits or genes of living cells and bacteria and uses the metabolic process to make necessary substances. However, it takes a long time to develop a new bacterial strain that will produce desired substances, and there is a limit to mass production of the strain.

To overcome these shortcomings and improve productivity, artificial intelligence (AI) and robot technology are mobilized at a biofoundry.

Collagen is a type of protein known to be effective in skin elasticity, anti-aging, and skin regeneration, and is plentiful in the bones and skin of vertebrates. The market size of collagen-related products came to about 121.9 billion won ($101 million) in 2019, more than fivefold in three years, according to the Ministry of Food and Drug Safety.

Kolmar Korea and Sungkyunkwan University are planning to synthesize a specific type of human collagen DNA into a microbial strain to secure a production strain and make human-like collagen through the process of mass culturing this strain. As a microbial strain, corynebacterium glutamicum is used, which is an industrial microbe traditionally used to produce amino acids.

Recombinant human-like collagen has a higher absorption rate than collagen derived from animals or plants and has fewer side effects such as allergies. Demand for this collagen is on the rise, but most of related raw materials are imported from abroad.

Synthetic biology is applied not only to cosmetics but also to various industries. It is also used to design and manufacture mRNA vaccines against COVID-19. Biofuels such as bioethanol and biodiesel are also made through synthetic biology. According to a national research center, the global synthetic biology market was worth $7.3 billion last year and is expected to grow to $10.5 billion by 2023.

[¨Ï Maeil Business Newspaper & mk.co.kr, All rights reserved]

Copyright © 매일경제 & mk.co.kr. 무단 전재, 재배포 및 AI학습 이용 금지

이 기사에 대해 어떻게 생각하시나요?